Sage Therapeutics Inc.: Sage Reports Positive Top-line Results Including Demonstration of 30-Day Durability from ... - The Wall Street Transcript

Sage Therapeutics Inc.: Sage Reports Positive Top-line Results Including Demonstration of 30-Day Durability from ... The Wall Street Transcript CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system disorders, today announced positive top-line results from its ... and more »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHfjps2uOk_4xSJ1RQHlLrc4QLsOA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779156634079&ei=hdKEV7GnJ9C33gHG65zADA&url=https://www.twst.com/update/sage-therapeutics-inc-sage-reports-positive-top-line-results-including-demonstration-of-30-day-durability-from-phase-2-clinical-trial-of-sage-547-in-severe-postpartum-depression/
via IFTTT